Project: Development of a sublingual mucosal immunization technology platform for needle-free vaccination
| Acronym | MucoVAC (Reference Number: 12830) |
| Duration | 31/05/2019 - 02/06/2022 |
| Project Topic | The consortium will develop a novel platform technology for sublingual vaccination. This project will deliver a validated and widely applicable technology consisting of sublingual delivery method and sublingual adjuvant with demonstrated capacity to load it with different types of antigens. In addition, for one specific vaccine the consortium will perform the pre-clinical testing, to demonstrate the efficacy of this platform technology. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 10 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | InStar Technologies a. s. | Coordinator | Czech Republic |
| 2 | Helmholtz-Zentrum für Infektionsforschung GmbH | Partner | Germany |
| 3 | LiteVax BV | Partner | Netherlands |
| 4 | Timeline Bioresearch AB | Partner | Sweden |
| 5 | Chimera Biotec GmbH | Partner | Germany |